Clinical trials

  • PATIROMER for End-stage renal disease (chronic dialysis)
  • ONA-255 for Advanced breast cancer | Metastatic gastric cancer | Gastroesophageal junction adenocarcinoma
  • ANAKINRA for Sepsis
  • CEMIPLIMAB for Locally advanced cervical carcinoma
  • DRONEDARONE HYDROCHLORIDE for Acute ischemic stroke | Atrial fibrillation
  • BNT327 for Metastatic colorectal cancer
  • ANUMIGILIMAB for Sickle cell disease
  • 7,8-DIBROMO-5,6-DIHYDRO-9-METHYL-2-(1-PIPERAZINYL)-4H-IMIDAZO[4,5,1-IJ]QUINOLINE HYDROCHLORIDE for Relapsed or refractory metastatic or advanced solid tumours | Myelofibrosis | High-risk myelodysplastic syndrome (relapsed/refractory) | Acute myeloid leukaemia (with or without NPM1 mutation)
  • MEROPENEM for Pyogenic liver abscess
  • PF-07868489 for Pulmonary arterial hypertension
  • JNJ-78278343 for Metastatic castration-resistant prostate cancer (mCRPC) | Hormone-refractory prostate cancer
  • DUVAKITUG for Ulcerative colitis|Moderately to severely active ulcerative colitis